ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors B. HolmPeter Buhl JensenMaxwell Sehested ORIGINAL ARTICLE Pages: 203 - 209
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues George E. DuranDerick H. M. LauB. I. Sikic ORIGINAL ARTICLE Pages: 210 - 216
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH K. MrossA. HüttmannD. K. Hossfeld ORIGINAL ARTICLE Pages: 217 - 224
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay G. W. AherneAnthea HardcastleLloyd R. Kelland ORIGINAL ARTICLE Pages: 225 - 232
Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs Shinichi UenoTakashi AikouToshikazu Nakamura ORIGINAL ARTICLE Pages: 233 - 237
Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture P. T. JainJ. T. PentoRobert A. Magarian ORIGNAL ARTICLE Pages: 238 - 244
Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*) Roger A. MooreheadSteven G. ArmstrongGurmit Singh ORIGINAL ARTICLE Pages: 245 - 253
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure L. J. C. van WarmerdamGeert-Jan CreemersJos H. Beijnen ORIGINAL ARTICLE Pages: 254 - 260
The effect of 9-β-D-arabinofuranosyl-2-fluoroadenine and 1-β-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells Susan LoughlinVarsha GandhiL. A. Zwelling ORIGINAL ARTICLE Pages: 261 - 268
Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3 F. CivoliSusan B. PauigL. W. Daniel ORIGINAL ARTICLE Pages: 269 - 272
The formation and persistence of carboplatin-DNA adducts in rats Frank A. BlommaertCharulla MichaelA. M. J. Fichtinger-Schepman ORIGINAL ARTICLE Pages: 273 - 280
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate Marie-France PinardJacques JolivetG. Jansen ORIGINAL ARTICLE Pages: 281 - 288
A phase II study of CI-973 [SP-4-3(R)]- [1, 1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N′) platinum in patients with refractory advanced breast cancer R. L. TheriaultRonald S. WaltersGabriel N. Hortobagyi ORIGINAL ARTICLE Pages: 289 - 291
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial A. PolyzosN. TsavarisP. Kosmidis CLINICAL TRIAL REPORT Pages: 292 - 297
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer M. NardiMarina Della GiuliaF. Calabresi CLINICAL TRIAL REPORT Pages: 298 - 301